MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Movement disorder associated with 3-Idroxyisobutyryl-Coa hydrolase (HIBCH) deficiency

    F. Nardecchia, L. Pollini, C. Carducci, M. Tolve, S. De Leo, C. Carducci, V. Leuzzi (Rome, Italy)

    Objective: To describe an early onset movement disorder due to impairment of valine metabolism. Background: HIBCH deficiency is a rare inborn error of valine metabolism…
  • 2018 International Congress

    Chinese patients with Wilson disease and the treatments: exampled with Unithiol (DMPS) intravenous infusion

    X.P. Wang (Shanghai, China)

    Objective: The authors performed a retrospective analysis about effects and side-effects for a series of 136 Chinese patients with Wilson disease, treated by Unithiol (DMPS)…
  • 2018 International Congress

    Expanding the clinical phenotype of BPAN: A case report

    M. Boca, A. Herwadkar, C. Breen, M. Silverdale, C. Kobylecki (Salford, United Kingdom)

    Objective: To describe an atypical presentation of a rare NBIA disorder Background: Beta-propeller protein-associated neurodegeneration (BPAN) manifests in infancy as an initially static encephalopathy with…
  • 2018 International Congress

    Exosomal alpha synuclein secretion is beneficial for cellular models of Kufor-Rakeb syndrome

    T. Tsunemi, Y. Ishiguro, A. Yoroisaka, W. Akamatsu, D. Krainc, N. Hattori (Tokyo, Japan)

    Objective: The purpose of this study is to investigate the effect of induction of exosomal a-syn secretion on PARK9-mediated neurotoxicity. Background: Kufor-Rakeb syndrome (KRS) is…
  • 2018 International Congress

    Neuropathology of a South Korean with Perry syndrome with DCTN1 T78C mutation

    S. Kim, E. Chung, J. Baik (Busan, Republic of Korea)

    Objective: To analyze macroscopic and microscopic findings of the Korean patient with Perry syndrome (PS), who had been already established about clinical features with genetic…
  • 2018 International Congress

    Contribution of the French registry in the understanding of Wilson disease

    A. Poujois, N. Girardot, A.S. Brunet, A. Lachaux, F. Woimant (Paris, France)

    Objective: To describe patients from the French Wilson disease (WD) registry. Background: WD is a rare genetic disorder caused by loss of function of the…
  • 2018 International Congress

    Does Niemann Pick Type C heterozygosity predispose to late-onset neurodegeneration?

    T. Bremova, C. Sztatecsny, M. Moser, A. Rominger, T. Stephan, J. Havla, K. Hartmann, D. Clevert, M. Strupp, S. Schneider (Munich, Germany)

    Objective: Do single NPC1 or NPC2 mutation also predispose to late-onset neurodegeneration, e. g. PD or dementia? Background: Niemann-Pick type C (NPC) is an autosomal…
  • 2018 International Congress

    Juvenile parkinsonism associated with a novel HSD17B10 mutation in a patient with HSD10 disease

    M. Rosário, O. Moldovan, S. Reimão, I. Chendo, J. Crawford, M. Rosa, L. Guedes (Lisbon, Portugal)

    Objective: We describe the case of a female patient with HSD10 disease associated with parkinsonism, with a novel mutation in the HSD17B10 gene. Background: HSD10…
  • 2018 International Congress

    Diagnostic tips from a case series of patients with Late Onset Tay Sachs disease

    G.M. Riboldi, K. Anstett, H. Lau (New York, NY, USA)

    Objective: To describe a population of eight patients with Late Onset Tay Sachs (LOTS) disease and offer tips to aid in diagnosing this rare condition.…
  • 2018 International Congress

    A Randomized Trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration

    T. Klopstock, F. Tricta, L. Neumayr, I. Karin, G. Zorzi, C. Fradette, T. Kmieć, B. Buechner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, P. Dušek, F. Zhao, F. Zibordi, N. Nardocci, C. Aguilar, S. Hayflick, M. Spino, A. Blamire, P. Hogarth, E. Vichinsky (Munich, Germany)

    Objective: To investigate whether treatment with the iron-chelating drug deferiprone (DFP) has benefit in patients with pantothenate kinase-associated neurodegeneration (PKAN), the most common form of…
  • « Previous Page
  • 1
  • …
  • 1446
  • 1447
  • 1448
  • 1449
  • 1450
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley